We are live on ! Find out more
MLTX icon

MoonLake Immunotherapeutics
MLTX

46 hedge funds and large institutions have $122M invested in MoonLake Immunotherapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

91.44% more ownership

Funds ownership: 0% → 91.44% (+91%)

Holders
46
Holders Change
+46
Holders Change %
–
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
46
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.36M
3
BlackRock
BlackRock
New York
+$7.96M
4
RI
RTW Investments
New York
+$7.96M
5
RCM
RA Capital Management
Massachusetts
+$7.43M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
$1.66M +$1.59M +150,000 New
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$796K +$743K +70,000 New
MF
28
Magnetar Financial
Illinois
$693K +$679K +63,951 New
MS
29
Maven Securities
Jersey
$571K +$531K +50,000 New
PC
30
Periscope Capital
Ontario, Canada
$565K +$531K +50,000 New
SCA
31
STALEY CAPITAL ADVISERS
Pennsylvania
$524K +$490K +46,121 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$485K +$475K +44,766 New
ECM
33
ExodusPoint Capital Management
New York
$393K +$367K +34,551 New
CIM
34
Cowen Investment Management
New York
$257K +$240K +22,647 New
Millennium Management
35
Millennium Management
New York
$227K +$212K +20,000 New
RCM
36
Radcliffe Capital Management
Pennsylvania
$227K +$212K +20,000 New
CC
37
Caxton Corporation
New Jersey
$182K +$170K +16,009 New
MWNA
38
Marshall Wace North America
New York
$164K +$160K +15,099 New
HF
39
HRT Financial
New York
$154K +$151K +14,258 New
CCM
40
Cinctive Capital Management
New York
$108K +$106K +10,000 New
OAC
41
OMERS Administration Corp
Ontario, Canada
$108K +$106K +10,000 New
PAM
42
Panagora Asset Management
Massachusetts
$103K +$101K +9,533 New
EAM
43
Exos Asset Management
New York
$57K +$53.1K +5,000 New
PHK
44
Point72 Hong Kong
Hong Kong
$2K +$2K +188 New
Morgan Stanley
45
Morgan Stanley
New York
– +$11 +1 New
TRCT
46
Tower Research Capital (TRC)
New York
– +$74 +7 New
1
2

MLTX Hedge Fund Activity: Q4 2020 in Review

46 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MoonLake Immunotherapeutics (MLTX) for Q4 2020, worth a combined $122M.

Buyers outnumbered sellers: 46 funds opened new MLTX positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $10.7M.

  • 46 institutional investors held MoonLake Immunotherapeutics (MLTX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $122M of MoonLake Immunotherapeutics stock for Q4 2020.
  • 46 funds opened new MoonLake Immunotherapeutics positions in Q4 2020 and 0 closed out, a net change of +46 holders.
  • The largest MoonLake Immunotherapeutics buyer in Q4 2020 was Adage Capital Partners, an estimated $10.7M added.

Based on aggregated 13F filings for Q4 2020.